A Model Approach to Calculate Cancer Prevalence From 5 Year Survival Data for Selected Cancer Sites in India

  • Published : 2013.11.30


Background: Prevalence is a statistic of primary interest in public health. In the absence of good follow-up facilities, it is difficult to assess the complete prevalence of cancer for a given registry area. Objective: An attempt was here made to arrive at complete prevalence including limited duration prevalence with respect to selected sites of cancer for India by fitting appropriate models to 1, 3 and 5 years cancer survival data available for selected population-based registries. Materials and Methods: Survival data, available for the registries of Bhopal, Chennai, Karunagappally, and Mumbai was pooled to generate survival for breast, cervix, ovary, lung, stomach and mouth cancers. With the available data on survival for 1, 3 and 5 years, a model was fitted and the survival curve was extended beyond 5 years (up to 35 years) for each of the selected sites. This helped in generation of survival proportions by single year and thereby survival of cancer cases. With the help of survival proportions available year-wise and the incidence, prevalence figures were arrived for selected cancer sites and for selected periods. Results: The prevalence to incidence ratio (PI ratio) stabilized after a certain duration for all the cancer sites showing that from the knowledge of incidence, the prevalence can be calculated. The stabilized P/I ratios for the cancer sites of breast, cervix, ovary, stomach, lung, mouth and for life time was observed to be 4.90, 5.33, 2.75, 1.40, 1.37, 4.04 and 3.42 respectively. Conclusions: The validity of the model approach to calculate prevalence could be demonstrated with the help of survival data of Barshi registry for cervix cancer, available for the period 1988-2006.


Survival;model;prevalence;breast cancer;cervix cancer;lung cancer


  1. ICMR Bulletin (2010). Time trends in cancer incidence rates: 1982-2005. Indian Council of Medical Research, 40, 11.
  2. Kruijshaar ME, Barendregt JJ, Hoeymans N (2002). The use of models in the estimation of disease epidemiology, Bulletin of the WHO. Bull World Health Organ, 80, 622-8.
  3. Kruijshaar ME, Barendreg JJ, Poll-Franse LVVD (2003): Estimating the prevalence of breast cancer using a disease model: data problems and trends. Population Health Metrics, 1, 5
  4. Merrill RM, Capocaccia R, Feuer EJ, Marioltto A (2000). Cancer Prevalence Estimates based on tumour registry data in the surveillance, Epidemiology and End Results (SEER) Programme. Int J Epidem, 29, 197-207.
  5. Nacul LC, Soljak M, Meade T (2007). Model for estimating the population prevalence of chronic obstructive pulmonary disease: cross sectional data from the Health Survey for England. Population Health Metrics, 5, 8.
  6. NCRP (2010). Three Year Report of Population Based Cancer Registries 2006-08, National Cancer Registry Programme, Indian Council of Medical Research.
  7. Sankaranarayanan R, Swaminathan R (2011). Cancer Survival in Africa, Asia, the Caribbean and Central America, IARC Scientific Publications No. 162.
  8. Takiar R, Nadayil D, Nandakumar A (2010). Projection of number of cancer cases in India (2010-2020) by cancer groups. Asian Pac J Cancer Prev, 11, 1045-49.

Cited by

  1. Genetic Polymorphisms of TCF7L2 Lack Influence on Risk of the Polycystic Ovary Syndrome - a Systemic Analysis vol.15, pp.7, 2014,